nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproterone acetate—AR—prostate cancer	0.144	0.398	CbGaD
Cyproterone acetate—CYP19A1—prostate cancer	0.121	0.333	CbGaD
Cyproterone acetate—AR—Bicalutamide—prostate cancer	0.118	0.298	CbGbCtD
Cyproterone acetate—AR—Nilutamide—prostate cancer	0.118	0.298	CbGbCtD
Cyproterone acetate—NR3C1—prostate cancer	0.0977	0.27	CbGaD
Cyproterone acetate—AR—Flutamide—prostate cancer	0.0976	0.247	CbGbCtD
Cyproterone acetate—AR—Estradiol—prostate cancer	0.0405	0.102	CbGbCtD
Cyproterone acetate—NR3C1—Prednisone—prostate cancer	0.0222	0.056	CbGbCtD
Cyproterone acetate—CYP19A1—semen—prostate cancer	0.00535	0.179	CbGeAlD
Cyproterone acetate—AR—penis—prostate cancer	0.00497	0.166	CbGeAlD
Cyproterone acetate—AR—semen—prostate cancer	0.00474	0.159	CbGeAlD
Cyproterone acetate—NR3C1—urine—prostate cancer	0.00239	0.0802	CbGeAlD
Cyproterone acetate—CYP19A1—prostate gland—prostate cancer	0.00134	0.0449	CbGeAlD
Cyproterone acetate—AR—prostate gland—prostate cancer	0.00119	0.0398	CbGeAlD
Cyproterone acetate—AR—seminal vesicle—prostate cancer	0.001	0.0336	CbGeAlD
Cyproterone acetate—AR—epithelium—prostate cancer	0.000872	0.0292	CbGeAlD
Cyproterone acetate—NR3C1—prostate gland—prostate cancer	0.00086	0.0288	CbGeAlD
Cyproterone acetate—AR—renal system—prostate cancer	0.000809	0.0271	CbGeAlD
Cyproterone acetate—AR—urethra—prostate cancer	0.000795	0.0266	CbGeAlD
Cyproterone acetate—Medroxyprogesterone Acetate—HSD3B2—prostate cancer	0.000786	0.302	CrCbGaD
Cyproterone acetate—NR3C1—seminal vesicle—prostate cancer	0.000727	0.0244	CbGeAlD
Cyproterone acetate—NR3C1—epithelium—prostate cancer	0.000632	0.0212	CbGeAlD
Cyproterone acetate—CYP19A1—testis—prostate cancer	0.000591	0.0198	CbGeAlD
Cyproterone acetate—NR3C1—renal system—prostate cancer	0.000586	0.0196	CbGeAlD
Cyproterone acetate—NR3C1—urethra—prostate cancer	0.000576	0.0193	CbGeAlD
Cyproterone acetate—AR—testis—prostate cancer	0.000523	0.0175	CbGeAlD
Cyproterone acetate—NR3C1—bone marrow—prostate cancer	0.000443	0.0148	CbGeAlD
Cyproterone acetate—Medroxyprogesterone Acetate—AKR1C3—prostate cancer	0.000435	0.167	CrCbGaD
Cyproterone acetate—CYP19A1—lymph node—prostate cancer	0.000428	0.0143	CbGeAlD
Cyproterone acetate—AR—lymph node—prostate cancer	0.000379	0.0127	CbGeAlD
Cyproterone acetate—NR3C1—testis—prostate cancer	0.000379	0.0127	CbGeAlD
Cyproterone acetate—Ethynodiol—ESR1—prostate cancer	0.000359	0.138	CrCbGaD
Cyproterone acetate—NR3C1—lymph node—prostate cancer	0.000275	0.00919	CbGeAlD
Cyproterone acetate—Megestrol acetate—NR3C1—prostate cancer	0.000231	0.0888	CrCbGaD
Cyproterone acetate—Medroxyprogesterone Acetate—SHBG—prostate cancer	0.000226	0.087	CrCbGaD
Cyproterone acetate—Medroxyprogesterone Acetate—AR—prostate cancer	0.000198	0.0763	CrCbGaD
Cyproterone acetate—Medroxyprogesterone Acetate—ESR1—prostate cancer	0.000153	0.0587	CrCbGaD
Cyproterone acetate—Medroxyprogesterone Acetate—NR3C1—prostate cancer	0.000134	0.0517	CrCbGaD
Cyproterone acetate—Medroxyprogesterone Acetate—CYP3A4—prostate cancer	7.79e-05	0.03	CrCbGaD
Cyproterone acetate—Asthenia—Mitoxantrone—prostate cancer	2.55e-05	0.000181	CcSEcCtD
Cyproterone acetate—Fatigue—Etoposide—prostate cancer	2.55e-05	0.000181	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	2.54e-05	0.000181	CcSEcCtD
Cyproterone acetate—Cough—Capecitabine—prostate cancer	2.54e-05	0.000181	CcSEcCtD
Cyproterone acetate—Jaundice—Epirubicin—prostate cancer	2.53e-05	0.00018	CcSEcCtD
Cyproterone acetate—Constipation—Etoposide—prostate cancer	2.53e-05	0.00018	CcSEcCtD
Cyproterone acetate—Dizziness—Estradiol—prostate cancer	2.52e-05	0.000179	CcSEcCtD
Cyproterone acetate—Sweating—Epirubicin—prostate cancer	2.49e-05	0.000177	CcSEcCtD
Cyproterone acetate—Pollakiuria—Doxorubicin—prostate cancer	2.49e-05	0.000177	CcSEcCtD
Cyproterone acetate—Haematuria—Epirubicin—prostate cancer	2.48e-05	0.000176	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	2.46e-05	0.000175	CcSEcCtD
Cyproterone acetate—Photosensitivity reaction—Doxorubicin—prostate cancer	2.46e-05	0.000175	CcSEcCtD
Cyproterone acetate—Hepatobiliary disease—Epirubicin—prostate cancer	2.46e-05	0.000175	CcSEcCtD
Cyproterone acetate—Oedema—Docetaxel—prostate cancer	2.46e-05	0.000174	CcSEcCtD
Cyproterone acetate—Weight increased—Doxorubicin—prostate cancer	2.45e-05	0.000174	CcSEcCtD
Cyproterone acetate—Discomfort—Capecitabine—prostate cancer	2.45e-05	0.000174	CcSEcCtD
Cyproterone acetate—Weight decreased—Doxorubicin—prostate cancer	2.44e-05	0.000173	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Etoposide—prostate cancer	2.44e-05	0.000173	CcSEcCtD
Cyproterone acetate—Hyperglycaemia—Doxorubicin—prostate cancer	2.43e-05	0.000173	CcSEcCtD
Cyproterone acetate—Diarrhoea—Mitoxantrone—prostate cancer	2.43e-05	0.000173	CcSEcCtD
Cyproterone acetate—Vomiting—Estradiol—prostate cancer	2.42e-05	0.000172	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Etoposide—prostate cancer	2.42e-05	0.000172	CcSEcCtD
Cyproterone acetate—Shock—Docetaxel—prostate cancer	2.42e-05	0.000172	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Docetaxel—prostate cancer	2.41e-05	0.000171	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Prednisone—prostate cancer	2.41e-05	0.000171	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Docetaxel—prostate cancer	2.41e-05	0.000171	CcSEcCtD
Cyproterone acetate—Rash—Estradiol—prostate cancer	2.4e-05	0.000171	CcSEcCtD
Cyproterone acetate—Dermatitis—Estradiol—prostate cancer	2.4e-05	0.000171	CcSEcCtD
Cyproterone acetate—Anaemia—Prednisone—prostate cancer	2.4e-05	0.00017	CcSEcCtD
Cyproterone acetate—Tachycardia—Docetaxel—prostate cancer	2.4e-05	0.00017	CcSEcCtD
Cyproterone acetate—Headache—Estradiol—prostate cancer	2.39e-05	0.00017	CcSEcCtD
Cyproterone acetate—Skin disorder—Docetaxel—prostate cancer	2.39e-05	0.000169	CcSEcCtD
Cyproterone acetate—Agitation—Prednisone—prostate cancer	2.39e-05	0.000169	CcSEcCtD
Cyproterone acetate—Oedema—Capecitabine—prostate cancer	2.38e-05	0.000169	CcSEcCtD
Cyproterone acetate—Renal failure—Doxorubicin—prostate cancer	2.36e-05	0.000168	CcSEcCtD
Cyproterone acetate—Urticaria—Etoposide—prostate cancer	2.35e-05	0.000167	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—NCOA3—prostate cancer	2.34e-05	0.000342	CbGpPWpGaD
Cyproterone acetate—Haemoglobin—Epirubicin—prostate cancer	2.34e-05	0.000166	CcSEcCtD
Cyproterone acetate—Jaundice—Doxorubicin—prostate cancer	2.34e-05	0.000166	CcSEcCtD
Cyproterone acetate—Anorexia—Docetaxel—prostate cancer	2.34e-05	0.000166	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—CTNNB1—prostate cancer	2.34e-05	0.000342	CbGpPWpGaD
Cyproterone acetate—Malaise—Prednisone—prostate cancer	2.34e-05	0.000166	CcSEcCtD
Cyproterone acetate—Shock—Capecitabine—prostate cancer	2.34e-05	0.000166	CcSEcCtD
Cyproterone acetate—Abdominal pain—Etoposide—prostate cancer	2.34e-05	0.000166	CcSEcCtD
Cyproterone acetate—Body temperature increased—Etoposide—prostate cancer	2.34e-05	0.000166	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—MDM2—prostate cancer	2.34e-05	0.000341	CbGpPWpGaD
Cyproterone acetate—Nervous system disorder—Capecitabine—prostate cancer	2.33e-05	0.000166	CcSEcCtD
Cyproterone acetate—Haemorrhage—Epirubicin—prostate cancer	2.33e-05	0.000166	CcSEcCtD
Cyproterone acetate—Hepatitis—Epirubicin—prostate cancer	2.33e-05	0.000166	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Capecitabine—prostate cancer	2.33e-05	0.000165	CcSEcCtD
Cyproterone acetate—Syncope—Prednisone—prostate cancer	2.33e-05	0.000165	CcSEcCtD
Cyproterone acetate—Tachycardia—Capecitabine—prostate cancer	2.32e-05	0.000165	CcSEcCtD
Cyproterone acetate—AR—Gene Expression—RPL12—prostate cancer	2.31e-05	0.000337	CbGpPWpGaD
Cyproterone acetate—Skin disorder—Capecitabine—prostate cancer	2.31e-05	0.000164	CcSEcCtD
Cyproterone acetate—Sweating—Doxorubicin—prostate cancer	2.3e-05	0.000164	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Capecitabine—prostate cancer	2.3e-05	0.000163	CcSEcCtD
Cyproterone acetate—Hypotension—Docetaxel—prostate cancer	2.3e-05	0.000163	CcSEcCtD
Cyproterone acetate—Haematuria—Doxorubicin—prostate cancer	2.29e-05	0.000163	CcSEcCtD
Cyproterone acetate—Connective tissue disorder—Epirubicin—prostate cancer	2.29e-05	0.000163	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—BCL2—prostate cancer	2.28e-05	0.000333	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—PTEN—prostate cancer	2.28e-05	0.000333	CbGpPWpGaD
Cyproterone acetate—Loss of consciousness—Prednisone—prostate cancer	2.28e-05	0.000162	CcSEcCtD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—CTNNB1—prostate cancer	2.28e-05	0.000333	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—NCOA1—prostate cancer	2.28e-05	0.000333	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CYP3A43—prostate cancer	2.27e-05	0.000332	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—AMACR—prostate cancer	2.27e-05	0.000332	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—SRD5A2—prostate cancer	2.27e-05	0.000332	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—NAT1—prostate cancer	2.27e-05	0.000332	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—DEGS1—prostate cancer	2.27e-05	0.000332	CbGpPWpGaD
Cyproterone acetate—Hepatobiliary disease—Doxorubicin—prostate cancer	2.27e-05	0.000161	CcSEcCtD
Cyproterone acetate—Anorexia—Capecitabine—prostate cancer	2.27e-05	0.000161	CcSEcCtD
Cyproterone acetate—Nausea—Estradiol—prostate cancer	2.27e-05	0.000161	CcSEcCtD
Cyproterone acetate—Vomiting—Mitoxantrone—prostate cancer	2.26e-05	0.00016	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—MDM2—prostate cancer	2.25e-05	0.000328	CbGpPWpGaD
Cyproterone acetate—Visual impairment—Epirubicin—prostate cancer	2.25e-05	0.00016	CcSEcCtD
Cyproterone acetate—Rash—Mitoxantrone—prostate cancer	2.24e-05	0.000159	CcSEcCtD
Cyproterone acetate—Dermatitis—Mitoxantrone—prostate cancer	2.24e-05	0.000159	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—HPGDS—prostate cancer	2.24e-05	0.000326	CbGpPWpGaD
Cyproterone acetate—Headache—Mitoxantrone—prostate cancer	2.23e-05	0.000158	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—CYP2C19—prostate cancer	2.22e-05	0.000324	CbGpPWpGaD
Cyproterone acetate—Hypotension—Capecitabine—prostate cancer	2.22e-05	0.000158	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—ERBB2—prostate cancer	2.22e-05	0.000323	CbGpPWpGaD
Cyproterone acetate—Erythema multiforme—Epirubicin—prostate cancer	2.21e-05	0.000157	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	2.19e-05	0.000156	CcSEcCtD
Cyproterone acetate—NR3C1—Gene Expression—EIF3H—prostate cancer	2.19e-05	0.00032	CbGpPWpGaD
Cyproterone acetate—Dyspnoea—Docetaxel—prostate cancer	2.19e-05	0.000156	CcSEcCtD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—TP53—prostate cancer	2.19e-05	0.000319	CbGpPWpGaD
Cyproterone acetate—Discomfort—Prednisone—prostate cancer	2.18e-05	0.000155	CcSEcCtD
Cyproterone acetate—Eye disorder—Epirubicin—prostate cancer	2.18e-05	0.000155	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Etoposide—prostate cancer	2.18e-05	0.000155	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—EP300—prostate cancer	2.18e-05	0.000317	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—HSD17B1—prostate cancer	2.17e-05	0.000316	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—ACHE—prostate cancer	2.17e-05	0.000316	CbGpPWpGaD
Cyproterone acetate—Haemoglobin—Doxorubicin—prostate cancer	2.17e-05	0.000154	CcSEcCtD
Cyproterone acetate—AR—Generic Transcription Pathway—RXRA—prostate cancer	2.17e-05	0.000316	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—PTGS2—prostate cancer	2.17e-05	0.000316	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—prostate cancer	2.16e-05	0.000316	CbGpPWpGaD
Cyproterone acetate—Dyspepsia—Docetaxel—prostate cancer	2.16e-05	0.000154	CcSEcCtD
Cyproterone acetate—Hepatitis—Doxorubicin—prostate cancer	2.16e-05	0.000153	CcSEcCtD
Cyproterone acetate—Haemorrhage—Doxorubicin—prostate cancer	2.16e-05	0.000153	CcSEcCtD
Cyproterone acetate—Decreased appetite—Docetaxel—prostate cancer	2.14e-05	0.000152	CcSEcCtD
Cyproterone acetate—AR—Gene Expression—EIF3A—prostate cancer	2.12e-05	0.000309	CbGpPWpGaD
Cyproterone acetate—Gastrointestinal disorder—Docetaxel—prostate cancer	2.12e-05	0.000151	CcSEcCtD
Cyproterone acetate—Asthenia—Etoposide—prostate cancer	2.12e-05	0.000151	CcSEcCtD
Cyproterone acetate—Connective tissue disorder—Doxorubicin—prostate cancer	2.12e-05	0.000151	CcSEcCtD
Cyproterone acetate—Dyspnoea—Capecitabine—prostate cancer	2.12e-05	0.000151	CcSEcCtD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—EP300—prostate cancer	2.12e-05	0.000309	CbGpPWpGaD
Cyproterone acetate—Oedema—Prednisone—prostate cancer	2.12e-05	0.00015	CcSEcCtD
Cyproterone acetate—Fatigue—Docetaxel—prostate cancer	2.12e-05	0.00015	CcSEcCtD
Cyproterone acetate—Angiopathy—Epirubicin—prostate cancer	2.12e-05	0.00015	CcSEcCtD
Cyproterone acetate—Nausea—Mitoxantrone—prostate cancer	2.11e-05	0.00015	CcSEcCtD
Cyproterone acetate—Immune system disorder—Epirubicin—prostate cancer	2.11e-05	0.00015	CcSEcCtD
Cyproterone acetate—Mediastinal disorder—Epirubicin—prostate cancer	2.1e-05	0.000149	CcSEcCtD
Cyproterone acetate—Constipation—Docetaxel—prostate cancer	2.1e-05	0.000149	CcSEcCtD
Cyproterone acetate—Dyspepsia—Capecitabine—prostate cancer	2.09e-05	0.000149	CcSEcCtD
Cyproterone acetate—Chills—Epirubicin—prostate cancer	2.09e-05	0.000149	CcSEcCtD
Cyproterone acetate—Pruritus—Etoposide—prostate cancer	2.09e-05	0.000149	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—CASP3—prostate cancer	2.09e-05	0.000305	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—AKR1C3—prostate cancer	2.09e-05	0.000304	CbGpPWpGaD
Cyproterone acetate—Shock—Prednisone—prostate cancer	2.08e-05	0.000148	CcSEcCtD
Cyproterone acetate—Visual impairment—Doxorubicin—prostate cancer	2.08e-05	0.000148	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Prednisone—prostate cancer	2.08e-05	0.000148	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PRKACB—prostate cancer	2.08e-05	0.000303	CbGpPWpGaD
Cyproterone acetate—Tachycardia—Prednisone—prostate cancer	2.07e-05	0.000147	CcSEcCtD
Cyproterone acetate—Decreased appetite—Capecitabine—prostate cancer	2.07e-05	0.000147	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—VEGFA—prostate cancer	2.06e-05	0.000301	CbGpPWpGaD
Cyproterone acetate—Alopecia—Epirubicin—prostate cancer	2.06e-05	0.000146	CcSEcCtD
Cyproterone acetate—Skin disorder—Prednisone—prostate cancer	2.06e-05	0.000146	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—CYP17A1—prostate cancer	2.05e-05	0.0003	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—prostate cancer	2.05e-05	0.0003	CbGpPWpGaD
Cyproterone acetate—Gastrointestinal disorder—Capecitabine—prostate cancer	2.05e-05	0.000146	CcSEcCtD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—NCOA2—prostate cancer	2.05e-05	0.000299	CbGpPWpGaD
Cyproterone acetate—Fatigue—Capecitabine—prostate cancer	2.05e-05	0.000146	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Prednisone—prostate cancer	2.05e-05	0.000145	CcSEcCtD
Cyproterone acetate—Mental disorder—Epirubicin—prostate cancer	2.04e-05	0.000145	CcSEcCtD
Cyproterone acetate—Erythema multiforme—Doxorubicin—prostate cancer	2.04e-05	0.000145	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—CCND1—prostate cancer	2.03e-05	0.000297	CbGpPWpGaD
Cyproterone acetate—Constipation—Capecitabine—prostate cancer	2.03e-05	0.000144	CcSEcCtD
Cyproterone acetate—Malnutrition—Epirubicin—prostate cancer	2.03e-05	0.000144	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Docetaxel—prostate cancer	2.02e-05	0.000144	CcSEcCtD
Cyproterone acetate—Diarrhoea—Etoposide—prostate cancer	2.02e-05	0.000144	CcSEcCtD
Cyproterone acetate—Anorexia—Prednisone—prostate cancer	2.02e-05	0.000143	CcSEcCtD
Cyproterone acetate—Eye disorder—Doxorubicin—prostate cancer	2.02e-05	0.000143	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—prostate cancer	2.01e-05	0.000294	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CASP3—prostate cancer	2.01e-05	0.000294	CbGpPWpGaD
Cyproterone acetate—Gastrointestinal pain—Docetaxel—prostate cancer	2.01e-05	0.000143	CcSEcCtD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—VEGFA—prostate cancer	2.01e-05	0.000293	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—AKT1—prostate cancer	2.01e-05	0.000293	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—CTNNB1—prostate cancer	2e-05	0.000292	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—IL6—prostate cancer	2e-05	0.000292	CbGpPWpGaD
Cyproterone acetate—Tension—Epirubicin—prostate cancer	1.99e-05	0.000141	CcSEcCtD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—PARP1—prostate cancer	1.98e-05	0.000289	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—VDR—prostate cancer	1.96e-05	0.000286	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—PTEN—prostate cancer	1.96e-05	0.000286	CbGpPWpGaD
Cyproterone acetate—Feeling abnormal—Capecitabine—prostate cancer	1.96e-05	0.000139	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CCND1—prostate cancer	1.96e-05	0.000286	CbGpPWpGaD
Cyproterone acetate—Angiopathy—Doxorubicin—prostate cancer	1.96e-05	0.000139	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—NCOA2—prostate cancer	1.96e-05	0.000285	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—CDKN1A—prostate cancer	1.96e-05	0.000285	CbGpPWpGaD
Cyproterone acetate—Dizziness—Etoposide—prostate cancer	1.95e-05	0.000139	CcSEcCtD
Cyproterone acetate—Immune system disorder—Doxorubicin—prostate cancer	1.95e-05	0.000138	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Capecitabine—prostate cancer	1.94e-05	0.000138	CcSEcCtD
Cyproterone acetate—Mediastinal disorder—Doxorubicin—prostate cancer	1.94e-05	0.000138	CcSEcCtD
Cyproterone acetate—Abdominal pain—Docetaxel—prostate cancer	1.94e-05	0.000138	CcSEcCtD
Cyproterone acetate—Body temperature increased—Docetaxel—prostate cancer	1.94e-05	0.000138	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—prostate cancer	1.94e-05	0.000283	CbGpPWpGaD
Cyproterone acetate—Chills—Doxorubicin—prostate cancer	1.94e-05	0.000138	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—B4GALT4—prostate cancer	1.93e-05	0.000282	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—HPGD—prostate cancer	1.93e-05	0.000282	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—TP53—prostate cancer	1.93e-05	0.000281	CbGpPWpGaD
Cyproterone acetate—Alopecia—Doxorubicin—prostate cancer	1.91e-05	0.000135	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—MYC—prostate cancer	1.9e-05	0.000277	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—prostate cancer	1.9e-05	0.000276	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—PTEN—prostate cancer	1.89e-05	0.000276	CbGpPWpGaD
Cyproterone acetate—Mental disorder—Doxorubicin—prostate cancer	1.89e-05	0.000134	CcSEcCtD
Cyproterone acetate—Urticaria—Capecitabine—prostate cancer	1.89e-05	0.000134	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Epirubicin—prostate cancer	1.88e-05	0.000134	CcSEcCtD
Cyproterone acetate—Abdominal pain—Capecitabine—prostate cancer	1.88e-05	0.000134	CcSEcCtD
Cyproterone acetate—Body temperature increased—Capecitabine—prostate cancer	1.88e-05	0.000134	CcSEcCtD
Cyproterone acetate—Vomiting—Etoposide—prostate cancer	1.88e-05	0.000133	CcSEcCtD
Cyproterone acetate—Malnutrition—Doxorubicin—prostate cancer	1.88e-05	0.000133	CcSEcCtD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—ESR2—prostate cancer	1.88e-05	0.000274	CbGpPWpGaD
Cyproterone acetate—Anaemia—Epirubicin—prostate cancer	1.88e-05	0.000133	CcSEcCtD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—CXCL8—prostate cancer	1.88e-05	0.000274	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—EP300—prostate cancer	1.87e-05	0.000273	CbGpPWpGaD
Cyproterone acetate—Agitation—Epirubicin—prostate cancer	1.87e-05	0.000133	CcSEcCtD
Cyproterone acetate—Dyspepsia—Prednisone—prostate cancer	1.86e-05	0.000132	CcSEcCtD
Cyproterone acetate—Rash—Etoposide—prostate cancer	1.86e-05	0.000132	CcSEcCtD
Cyproterone acetate—Dermatitis—Etoposide—prostate cancer	1.86e-05	0.000132	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—EGFR—prostate cancer	1.85e-05	0.000271	CbGpPWpGaD
Cyproterone acetate—Headache—Etoposide—prostate cancer	1.85e-05	0.000132	CcSEcCtD
Cyproterone acetate—Tension—Doxorubicin—prostate cancer	1.84e-05	0.000131	CcSEcCtD
Cyproterone acetate—Decreased appetite—Prednisone—prostate cancer	1.84e-05	0.000131	CcSEcCtD
Cyproterone acetate—Malaise—Epirubicin—prostate cancer	1.83e-05	0.00013	CcSEcCtD
Cyproterone acetate—Fatigue—Prednisone—prostate cancer	1.83e-05	0.00013	CcSEcCtD
Cyproterone acetate—Syncope—Epirubicin—prostate cancer	1.82e-05	0.000129	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—TNFRSF21—prostate cancer	1.82e-05	0.000265	CbGpPWpGaD
Cyproterone acetate—Leukopenia—Epirubicin—prostate cancer	1.82e-05	0.000129	CcSEcCtD
Cyproterone acetate—Constipation—Prednisone—prostate cancer	1.81e-05	0.000129	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Docetaxel—prostate cancer	1.81e-05	0.000129	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—EP300—prostate cancer	1.8e-05	0.000263	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—CASP3—prostate cancer	1.8e-05	0.000262	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—MBD2—prostate cancer	1.79e-05	0.000261	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—TET2—prostate cancer	1.79e-05	0.000261	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—DNMT3B—prostate cancer	1.79e-05	0.00026	CbGpPWpGaD
Cyproterone acetate—Loss of consciousness—Epirubicin—prostate cancer	1.78e-05	0.000127	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—prostate cancer	1.77e-05	0.000259	CbGpPWpGaD
Cyproterone acetate—Cough—Epirubicin—prostate cancer	1.77e-05	0.000126	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—MTAP—prostate cancer	1.77e-05	0.000258	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CYP7B1—prostate cancer	1.77e-05	0.000258	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—NR3C1—prostate cancer	1.77e-05	0.000258	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—IL6—prostate cancer	1.76e-05	0.000257	CbGpPWpGaD
Cyproterone acetate—Asthenia—Docetaxel—prostate cancer	1.76e-05	0.000125	CcSEcCtD
Cyproterone acetate—Nausea—Etoposide—prostate cancer	1.76e-05	0.000125	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—SRC—prostate cancer	1.75e-05	0.000256	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—RPL12—prostate cancer	1.75e-05	0.000256	CbGpPWpGaD
Cyproterone acetate—Hypersensitivity—Capecitabine—prostate cancer	1.75e-05	0.000124	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—KRAS—prostate cancer	1.75e-05	0.000256	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—RPL10—prostate cancer	1.75e-05	0.000255	CbGpPWpGaD
Cyproterone acetate—Feeling abnormal—Prednisone—prostate cancer	1.75e-05	0.000124	CcSEcCtD
Cyproterone acetate—NR3C1—Adipogenesis—STAT3—prostate cancer	1.75e-05	0.000255	CbGpPWpGaD
Cyproterone acetate—Ill-defined disorder—Doxorubicin—prostate cancer	1.74e-05	0.000124	CcSEcCtD
Cyproterone acetate—Pruritus—Docetaxel—prostate cancer	1.74e-05	0.000123	CcSEcCtD
Cyproterone acetate—Anaemia—Doxorubicin—prostate cancer	1.74e-05	0.000123	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Prednisone—prostate cancer	1.73e-05	0.000123	CcSEcCtD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—CTNNB1—prostate cancer	1.73e-05	0.000252	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—NCOA1—prostate cancer	1.73e-05	0.000252	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	1.73e-05	0.000252	CbGpPWpGaD
Cyproterone acetate—Agitation—Doxorubicin—prostate cancer	1.73e-05	0.000123	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—SULT1E1—prostate cancer	1.72e-05	0.000251	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—SRD5A1—prostate cancer	1.72e-05	0.000251	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—HIST1H2BG—prostate cancer	1.72e-05	0.000251	CbGpPWpGaD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	1.72e-05	0.000122	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—VEGFA—prostate cancer	1.71e-05	0.000249	CbGpPWpGaD
Cyproterone acetate—Discomfort—Epirubicin—prostate cancer	1.71e-05	0.000121	CcSEcCtD
Cyproterone acetate—Asthenia—Capecitabine—prostate cancer	1.71e-05	0.000121	CcSEcCtD
Cyproterone acetate—Malaise—Doxorubicin—prostate cancer	1.69e-05	0.00012	CcSEcCtD
Cyproterone acetate—Syncope—Doxorubicin—prostate cancer	1.68e-05	0.00012	CcSEcCtD
Cyproterone acetate—Urticaria—Prednisone—prostate cancer	1.68e-05	0.00012	CcSEcCtD
Cyproterone acetate—Pruritus—Capecitabine—prostate cancer	1.68e-05	0.00012	CcSEcCtD
Cyproterone acetate—Leukopenia—Doxorubicin—prostate cancer	1.68e-05	0.000119	CcSEcCtD
Cyproterone acetate—Diarrhoea—Docetaxel—prostate cancer	1.68e-05	0.000119	CcSEcCtD
Cyproterone acetate—Body temperature increased—Prednisone—prostate cancer	1.67e-05	0.000119	CcSEcCtD
Cyproterone acetate—Abdominal pain—Prednisone—prostate cancer	1.67e-05	0.000119	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	1.67e-05	0.000244	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—HIST1H4H—prostate cancer	1.66e-05	0.000242	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—NPPA—prostate cancer	1.66e-05	0.000242	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—AR—prostate cancer	1.66e-05	0.000242	CbGpPWpGaD
Cyproterone acetate—Oedema—Epirubicin—prostate cancer	1.66e-05	0.000118	CcSEcCtD
Cyproterone acetate—AR—Generic Transcription Pathway—PPARA—prostate cancer	1.66e-05	0.000242	CbGpPWpGaD
Cyproterone acetate—Loss of consciousness—Doxorubicin—prostate cancer	1.65e-05	0.000117	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	1.65e-05	0.000241	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—RXRA—prostate cancer	1.65e-05	0.00024	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ACSL4—prostate cancer	1.64e-05	0.00024	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—HSD17B3—prostate cancer	1.64e-05	0.00024	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—prostate cancer	1.64e-05	0.00024	CbGpPWpGaD
Cyproterone acetate—Cough—Doxorubicin—prostate cancer	1.64e-05	0.000116	CcSEcCtD
Cyproterone acetate—AR—Gene Expression—MED12—prostate cancer	1.63e-05	0.000238	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—MYC—prostate cancer	1.63e-05	0.000238	CbGpPWpGaD
Cyproterone acetate—Shock—Epirubicin—prostate cancer	1.63e-05	0.000116	CcSEcCtD
Cyproterone acetate—Diarrhoea—Capecitabine—prostate cancer	1.63e-05	0.000116	CcSEcCtD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—AKT1—prostate cancer	1.63e-05	0.000237	CbGpPWpGaD
Cyproterone acetate—Nervous system disorder—Epirubicin—prostate cancer	1.62e-05	0.000115	CcSEcCtD
Cyproterone acetate—Dizziness—Docetaxel—prostate cancer	1.62e-05	0.000115	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Epirubicin—prostate cancer	1.62e-05	0.000115	CcSEcCtD
Cyproterone acetate—NR3C1—Adipogenesis—TGFB1—prostate cancer	1.62e-05	0.000236	CbGpPWpGaD
Cyproterone acetate—Tachycardia—Epirubicin—prostate cancer	1.62e-05	0.000115	CcSEcCtD
Cyproterone acetate—Skin disorder—Epirubicin—prostate cancer	1.61e-05	0.000114	CcSEcCtD
Cyproterone acetate—NR3C1—Gene Expression—EIF3A—prostate cancer	1.61e-05	0.000235	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—EP300—prostate cancer	1.61e-05	0.000235	CbGpPWpGaD
Cyproterone acetate—Hyperhidrosis—Epirubicin—prostate cancer	1.6e-05	0.000114	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—EGFR—prostate cancer	1.6e-05	0.000233	CbGpPWpGaD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	1.59e-05	0.000113	CcSEcCtD
Cyproterone acetate—Discomfort—Doxorubicin—prostate cancer	1.58e-05	0.000112	CcSEcCtD
Cyproterone acetate—Anorexia—Epirubicin—prostate cancer	1.58e-05	0.000112	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—ARG2—prostate cancer	1.58e-05	0.00023	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—UMPS—prostate cancer	1.58e-05	0.00023	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PHGDH—prostate cancer	1.58e-05	0.00023	CbGpPWpGaD
Cyproterone acetate—Dizziness—Capecitabine—prostate cancer	1.57e-05	0.000112	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—MYC—prostate cancer	1.57e-05	0.000229	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	1.57e-05	0.000229	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TGFB1—prostate cancer	1.57e-05	0.000229	CbGpPWpGaD
Cyproterone acetate—Vomiting—Docetaxel—prostate cancer	1.56e-05	0.000111	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Prednisone—prostate cancer	1.56e-05	0.000111	CcSEcCtD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—TP53—prostate cancer	1.56e-05	0.000227	CbGpPWpGaD
Cyproterone acetate—Rash—Docetaxel—prostate cancer	1.55e-05	0.00011	CcSEcCtD
Cyproterone acetate—Hypotension—Epirubicin—prostate cancer	1.55e-05	0.00011	CcSEcCtD
Cyproterone acetate—Dermatitis—Docetaxel—prostate cancer	1.55e-05	0.00011	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—LDHB—prostate cancer	1.55e-05	0.000225	CbGpPWpGaD
Cyproterone acetate—Headache—Docetaxel—prostate cancer	1.54e-05	0.000109	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—EGFR—prostate cancer	1.54e-05	0.000224	CbGpPWpGaD
Cyproterone acetate—Oedema—Doxorubicin—prostate cancer	1.53e-05	0.000109	CcSEcCtD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—VEGFA—prostate cancer	1.52e-05	0.000222	CbGpPWpGaD
Cyproterone acetate—Asthenia—Prednisone—prostate cancer	1.52e-05	0.000108	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—CYP3A5—prostate cancer	1.52e-05	0.000221	CbGpPWpGaD
Cyproterone acetate—Vomiting—Capecitabine—prostate cancer	1.51e-05	0.000107	CcSEcCtD
Cyproterone acetate—Shock—Doxorubicin—prostate cancer	1.51e-05	0.000107	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—KRAS—prostate cancer	1.51e-05	0.00022	CbGpPWpGaD
Cyproterone acetate—Nervous system disorder—Doxorubicin—prostate cancer	1.5e-05	0.000107	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Doxorubicin—prostate cancer	1.5e-05	0.000107	CcSEcCtD
Cyproterone acetate—AR—Generic Transcription Pathway—ESR1—prostate cancer	1.5e-05	0.000219	CbGpPWpGaD
Cyproterone acetate—Rash—Capecitabine—prostate cancer	1.5e-05	0.000107	CcSEcCtD
Cyproterone acetate—Pruritus—Prednisone—prostate cancer	1.5e-05	0.000106	CcSEcCtD
Cyproterone acetate—Dermatitis—Capecitabine—prostate cancer	1.5e-05	0.000106	CcSEcCtD
Cyproterone acetate—Tachycardia—Doxorubicin—prostate cancer	1.5e-05	0.000106	CcSEcCtD
Cyproterone acetate—Headache—Capecitabine—prostate cancer	1.49e-05	0.000106	CcSEcCtD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—VDR—prostate cancer	1.49e-05	0.000217	CbGpPWpGaD
Cyproterone acetate—Skin disorder—Doxorubicin—prostate cancer	1.49e-05	0.000106	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Doxorubicin—prostate cancer	1.48e-05	0.000105	CcSEcCtD
Cyproterone acetate—Dyspnoea—Epirubicin—prostate cancer	1.48e-05	0.000105	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—PDHA1—prostate cancer	1.47e-05	0.000214	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—TCN2—prostate cancer	1.47e-05	0.000214	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GSTA3—prostate cancer	1.47e-05	0.000214	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—UCP3—prostate cancer	1.47e-05	0.000214	CbGpPWpGaD
Cyproterone acetate—Anorexia—Doxorubicin—prostate cancer	1.46e-05	0.000104	CcSEcCtD
Cyproterone acetate—Nausea—Docetaxel—prostate cancer	1.46e-05	0.000104	CcSEcCtD
Cyproterone acetate—Dyspepsia—Epirubicin—prostate cancer	1.46e-05	0.000104	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—KRAS—prostate cancer	1.45e-05	0.000212	CbGpPWpGaD
Cyproterone acetate—Diarrhoea—Prednisone—prostate cancer	1.45e-05	0.000103	CcSEcCtD
Cyproterone acetate—Decreased appetite—Epirubicin—prostate cancer	1.44e-05	0.000102	CcSEcCtD
Cyproterone acetate—Hypotension—Doxorubicin—prostate cancer	1.43e-05	0.000102	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Epirubicin—prostate cancer	1.43e-05	0.000102	CcSEcCtD
Cyproterone acetate—Fatigue—Epirubicin—prostate cancer	1.43e-05	0.000101	CcSEcCtD
Cyproterone acetate—Constipation—Epirubicin—prostate cancer	1.42e-05	0.000101	CcSEcCtD
Cyproterone acetate—Nausea—Capecitabine—prostate cancer	1.41e-05	0.0001	CcSEcCtD
Cyproterone acetate—Dizziness—Prednisone—prostate cancer	1.4e-05	9.95e-05	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—SLC22A3—prostate cancer	1.4e-05	0.000204	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—HSD3B1—prostate cancer	1.4e-05	0.000204	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—IL6—prostate cancer	1.39e-05	0.000203	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—RPS19—prostate cancer	1.39e-05	0.000203	CbGpPWpGaD
Cyproterone acetate—Dyspnoea—Doxorubicin—prostate cancer	1.37e-05	9.71e-05	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Epirubicin—prostate cancer	1.37e-05	9.7e-05	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—LPL—prostate cancer	1.36e-05	0.000198	CbGpPWpGaD
Cyproterone acetate—Gastrointestinal pain—Epirubicin—prostate cancer	1.35e-05	9.62e-05	CcSEcCtD
Cyproterone acetate—NR3C1—Gene Expression—DNMT3B—prostate cancer	1.35e-05	0.000198	CbGpPWpGaD
Cyproterone acetate—Dyspepsia—Doxorubicin—prostate cancer	1.35e-05	9.59e-05	CcSEcCtD
Cyproterone acetate—Vomiting—Prednisone—prostate cancer	1.35e-05	9.57e-05	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—GSTA4—prostate cancer	1.34e-05	0.000196	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—TBXAS1—prostate cancer	1.34e-05	0.000196	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—TP53—prostate cancer	1.34e-05	0.000195	CbGpPWpGaD
Cyproterone acetate—Rash—Prednisone—prostate cancer	1.34e-05	9.49e-05	CcSEcCtD
Cyproterone acetate—Dermatitis—Prednisone—prostate cancer	1.33e-05	9.48e-05	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—prostate cancer	1.33e-05	0.000195	CbGpPWpGaD
Cyproterone acetate—Decreased appetite—Doxorubicin—prostate cancer	1.33e-05	9.47e-05	CcSEcCtD
Cyproterone acetate—NR3C1—Gene Expression—RPL10—prostate cancer	1.33e-05	0.000194	CbGpPWpGaD
Cyproterone acetate—Headache—Prednisone—prostate cancer	1.33e-05	9.43e-05	CcSEcCtD
Cyproterone acetate—AR—Gene Expression—DNMT1—prostate cancer	1.33e-05	0.000194	CbGpPWpGaD
Cyproterone acetate—Gastrointestinal disorder—Doxorubicin—prostate cancer	1.32e-05	9.4e-05	CcSEcCtD
Cyproterone acetate—Fatigue—Doxorubicin—prostate cancer	1.32e-05	9.39e-05	CcSEcCtD
Cyproterone acetate—Urticaria—Epirubicin—prostate cancer	1.32e-05	9.35e-05	CcSEcCtD
Cyproterone acetate—AR—Generic Transcription Pathway—CREBBP—prostate cancer	1.32e-05	0.000192	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—AKT1—prostate cancer	1.32e-05	0.000192	CbGpPWpGaD
Cyproterone acetate—Constipation—Doxorubicin—prostate cancer	1.31e-05	9.31e-05	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	1.31e-05	0.000191	CbGpPWpGaD
Cyproterone acetate—Abdominal pain—Epirubicin—prostate cancer	1.31e-05	9.3e-05	CcSEcCtD
Cyproterone acetate—Body temperature increased—Epirubicin—prostate cancer	1.31e-05	9.3e-05	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—GSTA2—prostate cancer	1.31e-05	0.000191	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—HIST1H2BG—prostate cancer	1.3e-05	0.00019	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—NCOA2—prostate cancer	1.3e-05	0.00019	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	1.29e-05	0.000188	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ABCG5—prostate cancer	1.29e-05	0.000188	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—SULT1A1—prostate cancer	1.29e-05	0.000188	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—EZH2—prostate cancer	1.29e-05	0.000187	CbGpPWpGaD
Cyproterone acetate—Feeling abnormal—Doxorubicin—prostate cancer	1.26e-05	8.97e-05	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—GSTA1—prostate cancer	1.26e-05	0.000184	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—NPPA—prostate cancer	1.26e-05	0.000184	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—HIST1H4H—prostate cancer	1.26e-05	0.000184	CbGpPWpGaD
Cyproterone acetate—Nausea—Prednisone—prostate cancer	1.26e-05	8.94e-05	CcSEcCtD
Cyproterone acetate—AR—Gene Expression—PARP1—prostate cancer	1.26e-05	0.000183	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—PPARA—prostate cancer	1.26e-05	0.000183	CbGpPWpGaD
Cyproterone acetate—Gastrointestinal pain—Doxorubicin—prostate cancer	1.25e-05	8.9e-05	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—NAT2—prostate cancer	1.25e-05	0.000182	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GSTO1—prostate cancer	1.25e-05	0.000182	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—HSD3B2—prostate cancer	1.25e-05	0.000182	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—MED12—prostate cancer	1.24e-05	0.000181	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—SERPINE1—prostate cancer	1.23e-05	0.00018	CbGpPWpGaD
Cyproterone acetate—Hypersensitivity—Epirubicin—prostate cancer	1.22e-05	8.67e-05	CcSEcCtD
Cyproterone acetate—NR3C1—Adipogenesis—IL6—prostate cancer	1.22e-05	0.000178	CbGpPWpGaD
Cyproterone acetate—Urticaria—Doxorubicin—prostate cancer	1.22e-05	8.65e-05	CcSEcCtD
Cyproterone acetate—Body temperature increased—Doxorubicin—prostate cancer	1.21e-05	8.61e-05	CcSEcCtD
Cyproterone acetate—Abdominal pain—Doxorubicin—prostate cancer	1.21e-05	8.61e-05	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	1.2e-05	0.000175	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—LRP2—prostate cancer	1.19e-05	0.000174	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PLCB2—prostate cancer	1.19e-05	0.000174	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CYP2C18—prostate cancer	1.19e-05	0.000174	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—HSPA1A—prostate cancer	1.19e-05	0.000174	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—ESR2—prostate cancer	1.19e-05	0.000174	CbGpPWpGaD
Cyproterone acetate—Asthenia—Epirubicin—prostate cancer	1.19e-05	8.44e-05	CcSEcCtD
Cyproterone acetate—Pruritus—Epirubicin—prostate cancer	1.17e-05	8.33e-05	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—P4HB—prostate cancer	1.17e-05	0.000171	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—SLC22A1—prostate cancer	1.14e-05	0.000166	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—ESR1—prostate cancer	1.14e-05	0.000166	CbGpPWpGaD
Cyproterone acetate—Diarrhoea—Epirubicin—prostate cancer	1.13e-05	8.05e-05	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—AKT1—prostate cancer	1.13e-05	0.000165	CbGpPWpGaD
Cyproterone acetate—Hypersensitivity—Doxorubicin—prostate cancer	1.13e-05	8.02e-05	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	1.13e-05	0.000164	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—SULT2A1—prostate cancer	1.11e-05	0.000162	CbGpPWpGaD
Cyproterone acetate—Asthenia—Doxorubicin—prostate cancer	1.1e-05	7.81e-05	CcSEcCtD
Cyproterone acetate—AR—Gene Expression—NCOA1—prostate cancer	1.1e-05	0.00016	CbGpPWpGaD
Cyproterone acetate—Dizziness—Epirubicin—prostate cancer	1.1e-05	7.78e-05	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—MED12—prostate cancer	1.09e-05	0.000159	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	1.09e-05	0.000159	CbGpPWpGaD
Cyproterone acetate—Pruritus—Doxorubicin—prostate cancer	1.08e-05	7.7e-05	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—GNG5—prostate cancer	1.08e-05	0.000158	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—IL6—prostate cancer	1.05e-05	0.000154	CbGpPWpGaD
Cyproterone acetate—Vomiting—Epirubicin—prostate cancer	1.05e-05	7.48e-05	CcSEcCtD
Cyproterone acetate—NR3C1—Gene Expression—RPS19—prostate cancer	1.05e-05	0.000154	CbGpPWpGaD
Cyproterone acetate—Diarrhoea—Doxorubicin—prostate cancer	1.05e-05	7.45e-05	CcSEcCtD
Cyproterone acetate—Rash—Epirubicin—prostate cancer	1.04e-05	7.42e-05	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—NCOA3—prostate cancer	1.04e-05	0.000152	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—RXRA—prostate cancer	1.04e-05	0.000152	CbGpPWpGaD
Cyproterone acetate—Dermatitis—Epirubicin—prostate cancer	1.04e-05	7.41e-05	CcSEcCtD
Cyproterone acetate—Headache—Epirubicin—prostate cancer	1.04e-05	7.37e-05	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	1.03e-05	0.00015	CbGpPWpGaD
Cyproterone acetate—Dizziness—Doxorubicin—prostate cancer	1.01e-05	7.2e-05	CcSEcCtD
Cyproterone acetate—NR3C1—Gene Expression—DNMT1—prostate cancer	1.01e-05	0.000147	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—CREBBP—prostate cancer	9.98e-06	0.000146	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—HPGDS—prostate cancer	9.96e-06	0.000145	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CYP2C19—prostate cancer	9.9e-06	0.000144	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—NCOA2—prostate cancer	9.88e-06	0.000144	CbGpPWpGaD
Cyproterone acetate—Nausea—Epirubicin—prostate cancer	9.84e-06	6.99e-05	CcSEcCtD
Cyproterone acetate—NR3C1—Gene Expression—EZH2—prostate cancer	9.75e-06	0.000142	CbGpPWpGaD
Cyproterone acetate—Vomiting—Doxorubicin—prostate cancer	9.75e-06	6.92e-05	CcSEcCtD
Cyproterone acetate—Rash—Doxorubicin—prostate cancer	9.67e-06	6.87e-05	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—GSTT1—prostate cancer	9.66e-06	0.000141	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ACHE—prostate cancer	9.66e-06	0.000141	CbGpPWpGaD
Cyproterone acetate—Dermatitis—Doxorubicin—prostate cancer	9.66e-06	6.86e-05	CcSEcCtD
Cyproterone acetate—Headache—Doxorubicin—prostate cancer	9.6e-06	6.82e-05	CcSEcCtD
Cyproterone acetate—AR—Gene Expression—SIRT1—prostate cancer	9.59e-06	0.00014	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CYP2A6—prostate cancer	9.55e-06	0.000139	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—PARP1—prostate cancer	9.54e-06	0.000139	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	9.51e-06	0.000139	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—VDR—prostate cancer	9.46e-06	0.000138	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—SERPINE1—prostate cancer	9.36e-06	0.000136	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—AKR1C3—prostate cancer	9.29e-06	0.000136	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PRKACB—prostate cancer	9.24e-06	0.000135	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CYP17A1—prostate cancer	9.15e-06	0.000133	CbGpPWpGaD
Cyproterone acetate—Nausea—Doxorubicin—prostate cancer	9.11e-06	6.47e-05	CcSEcCtD
Cyproterone acetate—NR3C1—Gene Expression—HSPA1A—prostate cancer	9.04e-06	0.000132	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—ESR2—prostate cancer	9.04e-06	0.000132	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	9.02e-06	0.000132	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—NCOA2—prostate cancer	8.71e-06	0.000127	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—ERCC2—prostate cancer	8.65e-06	0.000126	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—NR3C1—prostate cancer	8.51e-06	0.000124	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—NCOA1—prostate cancer	8.33e-06	0.000121	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—SLC5A5—prostate cancer	8.31e-06	0.000121	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CYP2E1—prostate cancer	8.12e-06	0.000118	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—NQO1—prostate cancer	8.03e-06	0.000117	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—AR—prostate cancer	7.98e-06	0.000116	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—PPARA—prostate cancer	7.97e-06	0.000116	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—RXRA—prostate cancer	7.92e-06	0.000116	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—TH—prostate cancer	7.91e-06	0.000115	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	7.86e-06	0.000115	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CYP3A4—prostate cancer	7.83e-06	0.000114	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—MYC—prostate cancer	7.81e-06	0.000114	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	7.79e-06	0.000114	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CYP1B1—prostate cancer	7.7e-06	0.000112	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GGT1—prostate cancer	7.46e-06	0.000109	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—NCOA1—prostate cancer	7.34e-06	0.000107	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—SIRT1—prostate cancer	7.28e-06	0.000106	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—ESR1—prostate cancer	7.22e-06	0.000105	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—VDR—prostate cancer	7.17e-06	0.000105	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—RXRA—prostate cancer	6.99e-06	0.000102	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	6.79e-06	9.91e-05	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—COMT—prostate cancer	6.73e-06	9.81e-05	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GSTP1—prostate cancer	6.7e-06	9.77e-05	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ITPR1—prostate cancer	6.59e-06	9.61e-05	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—ERCC2—prostate cancer	6.56e-06	9.57e-05	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—EP300—prostate cancer	6.48e-06	9.45e-05	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—CREBBP—prostate cancer	6.33e-06	9.24e-05	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—TYMS—prostate cancer	6.23e-06	9.08e-05	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—GSTM1—prostate cancer	6.15e-06	8.98e-05	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—PPARA—prostate cancer	6.05e-06	8.83e-05	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—LPL—prostate cancer	6.04e-06	8.81e-05	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—SERPINE1—prostate cancer	5.94e-06	8.66e-05	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—MYC—prostate cancer	5.92e-06	8.64e-05	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CYP1A1—prostate cancer	5.83e-06	8.51e-05	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ERCC2—prostate cancer	5.79e-06	8.44e-05	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—ESR1—prostate cancer	5.48e-06	8e-05	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—MTHFR—prostate cancer	5.44e-06	7.93e-05	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PPARA—prostate cancer	5.34e-06	7.78e-05	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CAV1—prostate cancer	5.02e-06	7.32e-05	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—CREBBP—prostate cancer	4.8e-06	7.01e-05	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	4.79e-06	6.99e-05	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PIK3CG—prostate cancer	4.57e-06	6.67e-05	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—SERPINE1—prostate cancer	4.51e-06	6.57e-05	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—INS—prostate cancer	4.33e-06	6.31e-05	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CREBBP—prostate cancer	4.24e-06	6.18e-05	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PIK3CD—prostate cancer	4.02e-06	5.86e-05	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—NOS3—prostate cancer	3.79e-06	5.53e-05	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—MYC—prostate cancer	3.76e-06	5.48e-05	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PIK3CB—prostate cancer	3.5e-06	5.11e-05	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PTGS2—prostate cancer	3.47e-06	5.06e-05	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PTEN—prostate cancer	3.03e-06	4.41e-05	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—EP300—prostate cancer	2.89e-06	4.21e-05	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—MYC—prostate cancer	2.85e-06	4.16e-05	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—AKT1—prostate cancer	2.61e-06	3.8e-05	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—PIK3CA—prostate cancer	2.13e-06	3.11e-05	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—AKT1—prostate cancer	1.98e-06	2.88e-05	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—AKT1—prostate cancer	1.74e-06	2.54e-05	CbGpPWpGaD
